Romano Danesi

32PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental biogeochemistryPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Apr 29, 2026
The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patients.

|Apr 03, 2026
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale.

Marzia Del Re, Elvira Inglese, Emilio Bria

|May 14, 2025
Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

Anna Amela Valsecchi, Simona Pisegna, Andrea Antonuzzo

|May 10, 2025
The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety.

Livio Pagano, Romano Danesi, Edoardo Benedetti

|May 23, 2024
Opioid metabolism and drug-drug interaction in cancer.

Matti Aapro, Stefano Fogli, Bart Morlion

|Mar 13, 2024
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review.

Sara Mucherino, Valentina Lorenzoni, Isotta Triulzi

Pageof 6

Frequent Collaborators

13 joint publications

Marzia Del Re

4 joint publications

Stefano Fogli

3 joint publications

Stefania Crucitta

2 joint publications

Federico Cucchiara